The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
ALKERMES ORD | Equity | G01767105 | 7,185,750 | 275,000 | SH | SOLE | 275,000 | 0 | 0 | ||
ANGIODYNAMICS ORD | Equity | 03475V101 | 6,747,300 | 490,000 | SH | SOLE | 490,000 | 0 | 0 | ||
ASCENDIS PHARMA ADR REP ORD | Equity | 04351P101 | 5,495,850 | 45,000 | SH | SOLE | 45,000 | 0 | 0 | ||
ATRICURE ORD | Equity | 04963C209 | 2,219,000 | 50,000 | SH | SOLE | 50,000 | 0 | 0 | ||
BDX Jan3 260.0 P | Listed Option | 075887959 | 6,357,500 | 25,000 | SH | Put | SOLE | 25,000 | 0 | 0 | |
BIOGEN ORD | Equity | 09062X103 | 5,538,400 | 20,000 | SH | SOLE | 20,000 | 0 | 0 | ||
CAREDX ORD | Equity | 14167L103 | 342,300 | 30,000 | SH | SOLE | 30,000 | 0 | 0 | ||
CERUS ORD | Equity | 157085101 | 9,125,000 | 2,500,000 | SH | SOLE | 2,500,000 | 0 | 0 | ||
COLLEGIUM PHARMACEUTICAL ORD | Equity | 19459J104 | 8,978,400 | 387,000 | SH | SOLE | 387,000 | 0 | 0 | ||
DOCGO ORD | Equity | 256086109 | 2,651,250 | 375,000 | SH | SOLE | 375,000 | 0 | 0 | ||
FENNEC PHARMACEUTICALS ORD | Equity | 31447P100 | 2,044,800 | 213,000 | SH | SOLE | 213,000 | 0 | 0 | ||
ICU MEDICAL ORD | Equity | 44930G107 | 787,400 | 5,000 | SH | SOLE | 5,000 | 0 | 0 | ||
INMODE ORD | Equity | M5425M103 | 3,213,000 | 90,000 | SH | SOLE | 90,000 | 0 | 0 | ||
IRONWOOD PHARMA CL A ORD | Equity | 46333X108 | 2,168,250 | 175,000 | SH | SOLE | 175,000 | 0 | 0 | ||
LANTHEUS HOLDINGS ORD | Equity | 516544103 | 5,350,800 | 105,000 | SH | SOLE | 105,000 | 0 | 0 | ||
VERADIGM ORD | Equity | 01988P108 | 12,612,600 | 715,000 | SH | SOLE | 715,000 | 0 | 0 | ||
MERCK & CO ORD | Equity | 58933Y105 | 2,773,750 | 25,000 | SH | SOLE | 25,000 | 0 | 0 | ||
MAXCYTE ORD | Equity | 57777K106 | 546,000 | 100,000 | SH | SOLE | 100,000 | 0 | 0 | ||
NEOGEN ORD | Equity | 640491106 | 3,807,500 | 250,000 | SH | SOLE | 250,000 | 0 | 0 | ||
NANOSTRING TECHNOLOGIES ORD | Equity | 63009R109 | 239,100 | 30,000 | SH | SOLE | 30,000 | 0 | 0 | ||
PACIRA BIOSCIENCES ORD | Equity | 695127100 | 3,861,000 | 100,000 | SH | SOLE | 100,000 | 0 | 0 | ||
PHREESIA ORD | Equity | 71944F106 | 9,222,600 | 285,000 | SH | SOLE | 285,000 | 0 | 0 | ||
PLEXUS ORD | Equity | 729132100 | 1,595,415 | 15,500 | SH | SOLE | 15,500 | 0 | 0 | ||
QQQ Jan3 270.0 P | Listed Option | 46090E953 | 39,942,000 | 150,000 | SH | Put | SOLE | 150,000 | 0 | 0 | |
RADNET ORD | Equity | 750491102 | 1,883,000 | 100,000 | SH | SOLE | 100,000 | 0 | 0 | ||
RIGEL PHARMACEUTICALS ORD | Equity | 766559603 | 3,450,000 | 2,300,000 | SH | SOLE | 2,300,000 | 0 | 0 | ||
SI BONE ORD | Equity | 825704109 | 4,488,000 | 330,000 | SH | SOLE | 330,000 | 0 | 0 | ||
SOMALOGIC CL A ORD | Equity | 83444K105 | 627,500 | 250,000 | SH | SOLE | 250,000 | 0 | 0 | ||
SOMALOGIC EQY WARRANT | Warrant | 83444K105 | 50,200 | 20,000 | SH | Call | SOLE | 20,000 | 0 | 0 | |
SANOFI ADR REP 1 1/2 ORD | Equity | 80105N105 | 2,421,500 | 50,000 | SH | SOLE | 50,000 | 0 | 0 | ||
SPY Jan3 380.0 P | Listed Option | 78462F953 | 9,560,750 | 25,000 | SH | Put | SOLE | 25,000 | 0 | 0 | |
STREAMLINE HEALTH SOLUTIONS ORD | Equity | 86323X106 | 7,790,794 | 4,930,882 | SH | SOLE | 4,930,882 | 0 | 0 | ||
TACTILE SYSTEMS TECHNOLOGY ORD | Equity | 87357P100 | 2,927,400 | 255,000 | SH | SOLE | 255,000 | 0 | 0 | ||
TENET HEALTHCARE ORD | Equity | 88033G407 | 4,635,050 | 95,000 | SH | SOLE | 95,000 | 0 | 0 | ||
TURNING POINT BRANDS ORD | Equity | 90041L105 | 2,703,750 | 125,000 | SH | SOLE | 125,000 | 0 | 0 | ||
VIATRIS ORD | Equity | 92556V106 | 10,851,750 | 975,000 | SH | SOLE | 975,000 | 0 | 0 |